Results 161 to 170 of about 268,028 (214)

Lineage-Selective Dependencies in Pediatric Cancers. [PDF]

Cold Spring Harb Perspect Med
Ritter KE, Durbin AD.
europepmc   +1 more source

Identification of novel biomarkers and prognostic model for neuroblastoma using Mendelian randomization and transcriptomic analysis. [PDF]

Discov Oncol
Fu Y, Zhang N, Cheng J, Qin X, Zhou X, Du X, Wang Y, Wang J, Zhang D.   +8 more
europepmc   +1 more source

<i>In Vivo</i> Antitumor Activity of Allicin in a Pediatric Neuroblastoma Patient-derived Xenograft (PDX) Mouse Model. [PDF]

In Vivo
Schultz CR, Gruhlke MCH, Slusarenko AJ, Bachmann AS.   +3 more
europepmc   +1 more source

Overview and recent advances in the treatment of neuroblastoma

Expert Review of Anticancer Therapy, 2017
Sarah B Whittle, Valeria R Smith, E. Doherty, Sibo Zhao, S. McCarty, P. Zage   +5 more
semanticscholar   +1 more source

The Involvement of CSRP1 in Neuroblastoma Differentiation and Apoptosis Impacting Tumor-Suppressive Therapeutic Responses. [PDF]

FASEB J
Lin YH, Jiang JH, Chuang HC, Huang CC, Hsu WM, Wu MT, Chen TY, Lian WS, Chuang JH.   +8 more
europepmc   +1 more source

Global, regional, and national burden of neuroblastoma and peripheral nervous system tumours in individuals aged over 60 from 1990 to 2021: a trend analysis of global burden of disease study. [PDF]

J Health Popul Nutr
Ding Z, Chen Y, Huang G, Liao R, Zhang H, Zhou S, Liu X.   +6 more
europepmc   +1 more source

Neuroblastoma: clinical and biological approach to risk stratification and treatment

Cell and Tissue Research, 2018
Vanessa P. Tolbert, K. Matthay
semanticscholar   +1 more source

The polyamine transporter ATP13A3 mediates difluoromethylornithine-induced polyamine uptake in neuroblastoma. [PDF]

Mol Oncol
Azfar M, Gao W, Van den Haute C, Xiao L, Karsa M, Pandher R, Karsa A, Spurling D, Ronca E, Bongers A, Guo X, Mayoh C, Fayt Y, Schoofs A, Burns MR, Verhelst SHL, Norris MD, Haber M, Vangheluwe P, Somers K.   +19 more
europepmc   +1 more source

Enhancer invasion shapes MYCN-dependent transcriptional amplification in neuroblastoma

Nature Genetics, 2018
Rhamy Zeid, Matthew A. Lawlor, E. Poon, Jaime M. Reyes, M. Fulciniti, Michael A. Lopez, Thomas G. Scott, Behnam Nabet, Michael A. Erb, Georg E. Winter, Zoe Jacobson, Donald R. Polaski, Kristen L. Karlin, Rachel A. Hirsch, Nikhil Munshi, Thomas F. Westbrook, L. Chesler, Charles Y. Lin, J. Bradner   +18 more
semanticscholar   +1 more source

A clinical observational study of dinutuximab beta as first-line maintenance treatment for patients with high-risk neuroblastoma in China. [PDF]

BMC Pediatr
Yu X, Kang S, Ge J, Wang J.
europepmc   +1 more source